10Y UST5.21%-0.57%30Y MTG7.40%+1.65%SOFR3.88%-0.26%VNQ$90.35-0.87%XLRE$41.49-0.81%FED FUNDS3.88%
Real Estate Trail
Institutional Press Wire
PR Newswire · Capital

Caris Life Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026

Via PR Newswire · October 15, 2026
Compiled by Real Estate Trail Editorial · October 15, 2026

Why this matters

Capital markets activity continues to be defined by the rotation from bank balance sheets to non-bank lenders. Private credit funds have raised record dry powder; banks have tightened CRE underwriting standards for the sixth consecutive quarter. The result is a market where well-sponsored deals clear, and marginal credit pays a meaningful spread to do so. For LPs, the allocation conversation has shifted decisively toward real estate debt, with equity allocations being deployed more selectively into operator-led platforms.

Editorial analysis · Real Estate Trail Editorial

On the RET wire

  • Disclosed capital deal value tracked in October 2026: $10.8B across 31 reported transactions.

Computed from Real Estate Trail’s own tracked coverage

Excerpt from PR Newswire:
IRVING, Texas, Oct. 15, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading TechBio company, today announced it will report third quarter 2026 financial results on Wednesday, November 4, 2026. Caris Lif…
Read the full article at PR Newswire →

External link. Real Estate Trail does not republish source content.

Related coverage — Capital

PR Newswire · Charlotte · Capital

Craig Lewis Joins CPL to Expand National Placemaking Leadership

CHARLOTTE, N.C., Oct. 15, 2026 /PRNewswire/ -- As communities across the country continue to invest in vibrant downtowns, mixed-use districts, and public spaces that strengthen quality of life, CPL has appointed Craig…

30m ago